eGenesis Company
Xenotransplant
Investors
Industry:
Risk Mitigation
Last Funding Type:
Series C
Estimated Revenue:
$10M to $50M
Total Funding:
$265.00
Investors Number:
27
Headquarters:
USA
Investor Type:
Late Stage Venture
Last Funding Date:
2021
Founded Date:
2014
Employee Number:
11-50